澳大利亚正面临因自行注射多肽产品而引发的新兴健康危机。这一行为主要出于健身或美容目的，但使用者普遍不认为自己是吸毒者，且缺乏必要的安全指导 1。在新南威尔士州，与多肽相关的住院人数急剧上升，从2025年7月的5人激增至2026年9月的200多人 1。这种需求的爆发使传统的针具交换服务承受巨大压力，部分地区的针具自动售货机在补货后几小时内即被取空 1。
针对这一趋势，专家提出了五项基本安全准则，旨在降低感染风险：不要重复使用针头；绝不共享任何注射设备（包括小瓶和细菌抑菌水）；将小瓶内的物质视为未知来源并警惕感染迹象；使用利器盒处理废弃针头；以及前往针具交换服务获取支持 1。尽管澳大利亚治疗用品管理局（TGA）正寻求限制非法或多肽的黑灰市交易，但其措施无法解决已持有多肽者的即时安全问题 1。因此，文章呼吁政府增加对伤害减害项目的资金支持，并强调健康系统需调整信息传播渠道，以适应多肽使用者将其视为“健康/美容”产品而非毒品的认知现状 1。
A new demographic of individuals in Australia, primarily purchasing peptides online for fitness or cosmetic purposes, is self-administering injections without recognizing themselves as drug users. 1 This lack of identification has led to a surge in hospitalizations and placed immense pressure on traditional harm reduction services, such as needle exchange programs. 1 In New South Wales, the number of admissions related to peptide use rose dramatically from five cases in July 2025 to more than 200 by September 2026. 1 The strain on resources is evident in some areas where automated syringe vending machines are emptied within hours of being restocked. 1
Health experts emphasize that because these users view peptides as health or beauty products rather than illicit drugs, standard public health messaging must be adapted. 1 To address immediate safety risks, five fundamental guidelines have been issued: never reuse needles; do not share any injection equipment, including vials and bacteriostatic water; treat substances in vials as having unknown origins and monitor for signs of infection; dispose of used needles in sharps containers; and seek support from needle exchange services. 1 While the Therapeutic Goods Administration (TGA) is working to curb illegal gray-market transactions, authorities acknowledge that regulatory measures alone cannot resolve the immediate safety concerns of those who already possess peptides. 1 Consequently, there are calls for increased government funding for harm reduction projects to accommodate this specific population’s needs. 1
评论
还没有评论，欢迎留下第一条。